Intrinsic Value of S&P & Nasdaq Contact Us

NuCana plc NCNA NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • GB • USD

SharesGrow Score
50/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

There have been 9 recent insider transactions recorded for NuCana plc (NCNA), including 0 buys and 0 sells.

Notable insiders with recent activity include Griffith Hugh, Kay Andrew Martin, Webster Ian Alexander. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.

Insider Transactions — NCNA

Date Name Role Transaction Shares Avg. Price Value Shares Owned
2026-03-18 Griffith Hugh Chief Executive Officer Unknown 831,561,761 - - -
2026-03-18 Kay Andrew Martin Director Unknown 63,648,062 - - -
2026-03-18 Webster Ian Alexander See Remarks Unknown 54,352,798 - - -
2026-03-18 Bruce Theresa Margaret Ms Chief Operating Officer Unknown 55,139,594 - - -
2026-03-18 Leperlier Cyrille Director Unknown 39,466,743 - - -
2026-03-18 Bloss Jeffrey D. Chief Medical Officer Unknown 175,742,012 - - -
2026-03-18 Mellish Martin C.b. Director Unknown 42,362,799 - - -
2026-03-18 Harrison David James Head of Translational Medicine Unknown 77,520,679 - - -
2026-03-18 Levy Elliott M. Director Unknown 28,631,517 - - -
Informative Buy/Sell — open market transaction (most significant) Uninformative Buy — award, option exercise, conversion Uninformative Sell — tax withholding, award vest sale Neutral — gift, trust, expiry
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message